<DOC>
	<DOCNO>NCT00000910</DOCNO>
	<brief_summary>The purpose study collect medical information HIV-positive pregnant woman baby ( ) see study site . This information use help design future research study patient . The population HIV-positive pregnant woman baby see study site officially examine . In order design future study research best care patient , study examine important characteristic general number woman trial .</brief_summary>
	<brief_title>A Study Collect Information About HIV-Positive Pregnant Women Their Babies</brief_title>
	<detailed_description>The population serve affiliated ACTG sit officially describe . Anecdotal evidence , however , surface regard characteristic HIV-infected pregnant woman current standard care pregnancy . This chart abstraction study design define , accurately , pertinent characteristic general number woman trial . In medical chart abstraction study , pertinent information collect HIV-infected pregnant woman infant receive primary consultative care PACTG 367 study site . Part A profile HIV-infected woman receive care consultation study sit pregnancy outcome January 1 , 1998 July 1 , 1998 . [ AS PER AMENDMENT 04/12/02 : Part A closed enrollment . ] Part B profile HIV-infected pregnant woman receive primary consultative care pregnancy outcome follow July 1 , 1998 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria A patient may eligible study : Is HIVpositive woman . Is receive care study site study period infant receive care study site whose delivery information available . Had baby January 1 , 1998 .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>